HLA Class II Antigens on Melanoma Cells

[1]  D. Guerry,et al.  Defective antigen presentation by human melanoma cell lines cultured from advanced, but not biologically early, disease. , 1989, Journal of immunology.

[2]  G. Sozzi,et al.  Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma. , 1987, Journal of immunology.

[3]  A. Houghton,et al.  Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. , 1987, Cancer research.

[4]  M. Ferrarini,et al.  Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response , 1987, The Journal of experimental medicine.

[5]  D. Elder,et al.  Interferon-gamma regulates the T cell response to precursor nevi and biologically early melanoma. , 1987, Journal of immunology.

[6]  E. Unanue,et al.  The basis for the immunoregulatory role of macrophages and other accessory cells. , 1987, Science.

[7]  J. Lehmann,et al.  Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes , 1987, International journal of cancer.

[8]  F. Robertson,et al.  Characterization of an immunosuppressive factor derived from colon cancer cells. , 1987, Journal of immunology.

[9]  F. Real,et al.  Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells , 1987, The Journal of experimental medicine.

[10]  J. Kirkwood,et al.  Immune response to autologous human melanoma: implication of class I and II MHC products. , 1986, Biochimica et biophysica acta.

[11]  A. Houghton,et al.  Class II histocompatibility antigen expression in human melanocytes transformed by Harvey murine sarcoma virus (Ha-MSV) and Kirsten MSV retroviruses , 1986, The Journal of experimental medicine.

[12]  A. Anichini,et al.  Phenotypic profile of clones from early cultures of human metastatic melanomas and its modulation by recombinant interferon γ , 1986, International journal of cancer.

[13]  E. Krementz,et al.  Immunological heterogeneity in human melanoma: immunogenic alloantigen expression in autologous host. , 1986, Cancer research.

[14]  G. Ferrara,et al.  LOSS OF POLYMORPHIC RESTRICTION FRAGMENTS OF CLASS I AND CLASS II MHC GENES IN A MALIGNANT MELANOMA , 1986, Journal of immunogenetics.

[15]  S. Ferrone,et al.  Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin. , 1986, Human immunology.

[16]  A. Anichini,et al.  Heterogeneity of clones from a human metastatic melanoma detected by autologous cytotoxic T lymphocyte clones , 1986, The Journal of experimental medicine.

[17]  P. Nowell,et al.  Karyotypic evolution in human malignant melanoma. , 1986, Cancer genetics and cytogenetics.

[18]  D. Taramelli,et al.  Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions. , 1986, Cancer research.

[19]  M. Melamed,et al.  Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. , 1985, Cancer research.

[20]  D J Ruiter,et al.  Phenotypic dynamics of tumor progression in human malignant melanoma , 1985, International journal of cancer.

[21]  A. Houghton,et al.  Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. N. Epstein,et al.  A study of tumor progression: the precursor lesions of superficial spreading and nodular melanoma. , 1984, Human pathology.

[23]  D. Taramelli,et al.  The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA‐DR antigens on the tumor cells , 1984, International journal of cancer.

[24]  J. D. Capra,et al.  Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations. , 1984, Journal of immunology.

[25]  D. Ruiter,et al.  Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens. , 1984, Cancer research.

[26]  J. Mach,et al.  Antigenic heterogeneity of clones and subclones from human melanoma cell lines demonstrated by a panel of monoclonal antibodies and flow microfluorometry analysis , 1984, International journal of cancer.

[27]  J. Strominger,et al.  HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure. , 1984, Journal of immunology.

[28]  A. Al-Katib,et al.  Leu‐10 (HLA‐DC/DS) antigen distribution in human leukaemic disorders as detected by a monoclonal antibody: correlation with HLA‐DR expression , 1984, British journal of haematology.

[29]  S. Ferrone,et al.  Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens. , 1984, Journal of the National Cancer Institute.

[30]  A. Houghton,et al.  Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon , 1984, The Journal of experimental medicine.

[31]  D. Taramelli,et al.  Primary but not metastatic human melanomas expressing dr antigens stimulate autologous lymphocytes , 1984, International journal of cancer.

[32]  L. Old,et al.  Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity? , 1984, Nature.

[33]  M. Pollack,et al.  Functional characteristics and differential expression of class II DR, DS, and SB antigens on human melanoma cell lines. , 1984, Human immunology.

[34]  S. Besuschio,et al.  Homogeneously staining regions (HSR) in a human malignant melanoma. , 1984, Cancer genetics and cytogenetics.

[35]  M. Herlyn,et al.  HLA-DR histocompatibility leukocyte antigens permit cultured human melanoma cells from early but not advanced disease to stimulate autologous lymphocytes. , 1984, The Journal of clinical investigation.

[36]  Y. Takahashi,et al.  Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells. , 1983, Journal of immunology.

[37]  P. Erb,et al.  Accessory cell-dependent selection of specific T-cell functions , 1983, Nature.

[38]  J. Klein,et al.  The nature of the interaction between suppressor and helper T cells in the response to LDHB. , 1983, Journal of immunology.

[39]  M. Greene,et al.  Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen. , 1983, Journal of immunology.

[40]  J. Roth,et al.  Immunoregulatory factors derived from human tumors. II. Partial purification and further immunobiochemical characterization of a human sarcoma-derived immunosuppressive factor expressing HLA-DR and immunoglobulin-related determinants. , 1983, Journal of immunology.

[41]  J. Cairncross,et al.  Surface antigens of melanocytes and melanomas. Markers of melanocyte differentiation and melanoma subsets , 1982, The Journal of experimental medicine.

[42]  Pollack Ms.  The detection of weak allogeneic stimulation by DR-positive tumor cell lines. , 1981 .

[43]  A. Houghton,et al.  Heterogeneity in surface antigen and glycoprotein expression of cell lines derived from different melanoma metastases of the same patient. Implications for the study of tumor antigens , 1981, The Journal of experimental medicine.

[44]  I. Fidler,et al.  Interactions among clonal subpopulations affect stability of the metastatic phenotype in polyclonal populations of B16 melanoma cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[45]  W. Dippold,et al.  Analysis of the biosynthesis of HLA-DR glycoproteins in human malignant melanoma cell lines. , 1981, Journal of immunology.

[46]  W. Clark,et al.  Specific immunoreactivity of hybridoma-secreted monoclonal anti-melanoma antibodies to cultured cells and freshly derived human cells. , 1980, Cancer research.

[47]  E. Engleman,et al.  Ia antigen on peripheral blood mononuclear leukocytes in man. II. Functional studies of HLA-DR-positive T cells activated in mixed lymphocyte reactions. , 1980, The Journal of experimental medicine.

[48]  S. Ferrone,et al.  DR (Ia-like) antigens on human melanoma cells. Serological detection and immunochemical characterization , 1979, The Journal of experimental medicine.

[49]  M. Taniguchi,et al.  MULTIPLE MHC LOCI CONTROLLING LYMPHOCYTE INTERACTIONS , 1979 .

[50]  C. Y. Wang,et al.  Expression of Ia-like antigens on cultured human malignant melanoma cell lines. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[51]  M. Greene,et al.  Regulation of the immune response to tumor antigens. II. The nature of immunosuppressor cells in tumor-bearing hosts. , 1976, Journal of immunology.